Currently out of the existing stock ratings of Peter Welford, 23 are a HOLD (34.33%), 34 are a BUY (50.75%), 10 are a SELL (14.93%).

Peter Welford

Work Performance Price Targets & Ratings Chart

Analyst Peter Welford, carries an average stock price target met ratio of 63.67% that have a potential upside of 23.9% achieved within 352 days. Previously, Peter Welford worked at JEFFERIES.

Peter Welford’s has documented 107 price targets and ratings displayed on 11 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on SNY, Sanofi ADR at 10-Dec-2024.

Wall Street Analyst Peter Welford

Analyst best performing recommendations are on PLX (PROTALIX BIOTHERAPEUTICS).
The best stock recommendation documented was for PLX (PROTALIX BIOTHERAPEUTICS) at 11/9/2012. The price target of $55 was fulfilled within 14 days with a profit of $6 (12.24%) receiving and performance score of 8.75.

Average potential price target upside

of $176.87 (29.75%) on RH (RH).
of $23.73 (27.21%) on NVS (NOVARTIS AG ADR).
of $23.66 (24.94%) on NVO (NOVO NORDISK A/S).

AZN AstraZeneca PLC ADR GSK GlaxoSmithKline PLC ADR PLX Protalix Biotherapeutics CGEN Compugen GLPG Galapagos NV ADR GMAB Genmab AS NVO Novo Nordisk A/S NVS Novartis AG ADR SNY Sanofi ADR RHHBY Roche Holding Ltd ADR RH RH

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Steve Scala (TD COWEN)